Amivantamab Lazertinib Combo for Non-Small Cell Lung Cancer: Novel Mechanisms of Action PHARMACOLOGY
5:03
Understanding NSCLC Treatment When You Have an EGFR Mutation
5:06
Marstacimab for Hemophilia A and B: Mechanism of Action │PHARMACOLOGY
5:53
Targeted Therapy in Non-Small Cell Lung Cancer
4:27
Tirzepatide: How Does It Work for Weight Loss? │ Pharmacology
2:21
What is an EGFR mutation in lung cancer?
15:04
SON EVRE KANSERDEN HAYATA DÖNÜŞ | MUCİZE DEĞİL BİLİM | Kemoterapi yerine kişiye özel gen odaklı ilaç
24:11
İYOT EKSİKLİĞİ BELİRTİLERİ , İyot Eksikliği Tedavisi , İyot Takviyesi Lugol Fizyoterapist Aynur BAŞ
46:03